| Health / Medical Topics |
T-DM1
A drug used to treat HER2-positive breast cancer that has spread to other parts of the body. It is used in patients who have already been treated with the anticancer drug called trastuzumab and a type of drug called a taxane. It may also be used in patients whose cancer has recurred (come back) after adjuvant therapy with these drugs. It is also being studied in the treatment of other types of cancer. T-DM1 contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. T-DM1 is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and Kadcyla. (NCI Dictionary)
YOU MAY ALSO LIKE
A probability distribution that arises in the problem of estimating the mean of a normally distributed population when the sample size is…
A large B-cell lymphoma characterized by the presence of a limited number of scattered neoplastic large B-lymphocytes which are admixed with numerous…
Morphologic alteration of small T lymphocytes in culture into large blast-like cells able to synthesize DNA and RNA and to divide…
T-cell surface glycoprotein CD8 alpha chain (235 aa, ~26 kDa) is encoded by the human CD8A gene. This protein is involved in…
T-cell surface glycoprotein CD5 (495 aa, ~54 kDa) is encoded by the human CD5 gene. This protein may be involved in regulating…
T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in…
